Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares US Financials ETF
IYF
$4.62B
| $53.1M | 0.03% |
643,178
+39,517
| +7% | +$3.28M |
|
202
Intuit
INTU
$88.5B
| $51.6M | 0.03% |
95,692
+94,753
| +10,091% | +$51.1M |
|
203
Boeing
BA
$187B
| $51.5M | 0.03% |
234,138
-5,839
| -2% | -$1.3M |
|
|
JHG
204
DELISTED
Janus Henderson
JHG
| $51.1M | 0.03% |
1,236,434
-19,386
| -2% | -$806K |
|
205
iShares US Medical Devices ETF
IHI
$3.36B
| $50.9M | 0.03% |
810,686
+47,360
| +6% | +$3.02M |
|
206
Vericel Corp
VCEL
$2.37B
| $50.8M | 0.03% |
1,040,040
+308,948
| +42% | +$16M |
|
207
Boston Beer
SAM
$1.92B
| $50.4M | 0.03% |
98,880
-3,178
| -3% | -$2.16M |
|
208
iShares MBS ETF
MBB
$39.1B
| $50.4M | 0.03% |
465,801
+15,951
| +4% | +$1.73M |
|
|
UMPQ
209
DELISTED
Umpqua Holdings Corp
UMPQ
| $49.4M | 0.03% |
2,438,645
-28,214
| -1% | -$541K |
|
210
Integer Holdings
ITGR
$4.25B
| $48.8M | 0.03% |
545,781
-16,822
| -3% | -$1.57M |
|
211
Qualcomm
QCOM
$171B
| $47.8M | 0.03% |
370,874
+6,204
| +2% | +$880K |
|
212
Knowles
KN
$3.45B
| $47.4M | 0.03% |
2,527,961
-31,790
| -1% | -$622K |
|
213
NETSCOUT
NTCT
$3.07B
| $46.7M | 0.03% |
1,733,352
-35,085
| -2% | -$973K |
|
214
Diageo
DEO
$48.8B
| $46.2M | 0.03% |
239,441
-117
| -0% | -$22.7K |
|
215
Wintrust Financial
WTFC
$11B
| $45.9M | 0.03% |
571,701
-15,639
| -3% | -$1.15M |
|
|
NUVA
216
DELISTED
NuVasive, Inc.
NUVA
| $45.6M | 0.03% |
762,553
-10,210
| -1% | -$630K |
|
|
PACW
217
DELISTED
PacWest Bancorp
PACW
| $44.8M | 0.03% |
987,442
-17,930
| -2% | -$744K |
|
218
Veracyte
VCYT
$3.73B
| $44.5M | 0.03% |
957,501
+713,726
| +293% | +$31.1M |
|
219
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.29B
| $44M | 0.03% |
1,080,066
+55,606
| +5% | +$2.5M |
|
220
Rockwell Automation
ROK
$49.5B
| $44M | 0.03% |
149,497
+4,459
| +3% | +$1.37M |
|
221
Plexus
PLXS
$7.41B
| $43.9M | 0.03% |
491,532
-4,716
| -1% | -$419K |
|
222
BioCryst Pharmaceuticals
BCRX
$2.29B
| $43.2M | 0.03% |
3,005,622
+994,391
| +49% | +$15.7M |
|
223
Nice
NICE
$6.05B
| $42.6M | 0.03% |
150,143
-17,941
| -11% | -$4.98M |
|
224
ON Semiconductor
ON
$31.4B
| $42.6M | 0.03% |
930,528
+62,408
| +7% | +$2.67M |
|
225
Gerdau
GGB
$10B
| $42.1M | 0.03% |
10,769,815
-1,106,977
| -9% | -$4.82M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.